Name: Equity Multiplier

Definition: The equity multiplier shows how much total assets the company controls for every dollar invested by shareholders. It reflects how much debt is being used to stretch owners’ equity. A higher multiplier means greater use of debt to amplify returns — but also amplifies risk if things go wrong. Lower multipliers suggest a safer, more self-funded business.

Interpretation:
• In '2021', NAUT's equity multiplier was 1.10, representing the level of financial leverage utilized. Industry average for Biotechnology: Laboratory Analytical Instruments in '2021' stood at 2.02.
• In '2022', NAUT's equity multiplier was 1.11, representing the level of financial leverage utilized. The increase compared to '2021' may signal growing financial pressure. Industry average for Biotechnology: Laboratory Analytical Instruments in '2022' stood at 1.70. Industry average declined by 0.32 from previous year.
• In '2023', NAUT's equity multiplier was 1.15, representing the level of financial leverage utilized. The increase compared to '2022' may signal growing financial pressure. Industry average for Biotechnology: Laboratory Analytical Instruments in '2023' stood at 1.43. Industry average declined by 0.27 from previous year.
• In '2024', NAUT's equity multiplier was 1.16, representing the level of financial leverage utilized. The increase compared to '2023' may signal growing financial pressure. Industry average for Biotechnology: Laboratory Analytical Instruments in '2024' stood at 1.68. Industry average increased by 0.25 compared to previous year.
Overall, NAUT's equity multiplier has steadily improved over the past 4 years.

Formula: Equity Multiplier = Total Assets / Shareholders' Equity

Good Range: Usually ranges from 1.5 to 3 depending on industry.